Biohacking Market Is Estimated To Witness High Growth Owing To Opportunity Of Personalized Health Management
Biohacking involves enhancing or modifying functions of the human body through external means such as implants, nutrition and genetics. It includes practices such as using nootropic supplements, genetic modification and sensory enhancement devices. Biohacking aids in controlling and optimizing human biology and improving cognitive abilities, physical strength and health. Adoption of biohacking techniques enables individuals to take control of their health and make lifestyle changes to achieve peak performance.
The global Biohacking Market is estimated to be valued at US$ 21567.42 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Personalized health management offers a key opportunity in the biohacking market. Biohacking allows tracking of numerous biological metrics through wearable sensors and devices which can help individuals make lifestyle changes for chronic disease management as per their requirements. Growing cases of lifestyle diseases like diabetes, obesity and cardiovascular conditions have increased focus on personalized nutrition and healthcare. Biohacking enables monitoring health parameters and customizing diet, supplements and exercise routine based on an individual's genetic profile, metabolism and response to therapies. This facilitates proactive disease management for better quality of life. The opportunity for personalized health management through precise biohacking tools is expected to drive high demand and adoption in the coming years.
Porter's Analysis
Threat of new entrants: The threat of new entrants in the biohacking market is moderate due to the high development cost associated with R&D activities and technical expertise required.
Bargaining power of buyers: The bargaining power of buyers is high due to the presence of a large number of players operating in the market providing similar products and services.
Bargaining power of suppliers: The bargaining power of suppliers is moderate due to differentiated products offered by suppliers and possibility of forward integration by big players.
Threat of new substitutes: The threat of new substitutes is low as biohacking has limited substitutes.
Competitive rivalry: The competitive rivalry in the biohacking market is high due to the presence of big players.
SWOT Analysis
Strength: The biohacking market has opportunities for innovations due to technological advancements. It allows modifying one's body and treating diseases.
Weakness: Lack of regulations, safety, and ethical issues related to biohacking are major weaknesses. High infrastructure and R&D costs associated with biohacking are other weaknesses.
Opportunity: Growing aging population demanding anti-aging solutions and rising precedence for customized healthcare present opportunities. Growing investment in synthetic biology and biotechnology also presents opportunities.
Threats: Stringent regulations around biohacking pose threats. Religious and ethical objections to modifying human body is another threat.
Key Takeaways
The global Biohacking Market Growth is expected to witness high growth during the forecast period owing to rising investment in life sciences and increasing demand for personalized healthcare. The global Biohacking Market is estimated to be valued at US$ 21567.42 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030.
The North American region currently dominates the market and is expected to continue its dominance in the coming years due to increasing adoption of DIY biohacking practices and presence of major players in the US. Asia Pacific is expected to be the fastest growing region in the biohacking market during the forecast period. This can be attributed to growing aging population, rising healthcare expenditure, increasing focus on preventive healthcare, and developing healthcare infrastructure in emerging countries of Asia Pacific.
Key players operating in the biohacking market are PepsiCo Inc., Red Bull GmbH, The Coca-Cola Company, Danone SA, Monster Beverage Corporation, JAB Holdings Company, General Nutrition Centers Inc., The Hain Celestial Group Inc., Fonterra Co-operative Group, and Amway Corporation. These players are focusing on new product launches, mergers, acquisitions and collaborations to gain market share.
For more insights, read- https://www.newsstatix.com/biohacking-market-trends-size-and-share-analysis-3/
For more details on the report, Read- https://www.ukwebwire.com/luxury-travel-market-trends-size-and-share-analysis/
